Educação em saúde Intensiva na atenção primária à saúde em Pacientes Com Diabetes Mellitus Tipo 2: um Ensaio clínico Randomizado - The Diabetes Care (D-CARE) Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 174
- 试验地点
- 3
- 主要终点
- Glycemic control
研究概览
简要总结
Type 2 diabetes mellitus (T2DM) leads to a high burden of morbidity and mortality, usually attributable to cardiovascular (CVD) causes. A major concern about the disease is that the success of the treatment is highly dependent on self-management, which very often incurs the necessity of behavior change. However, modifying such behaviors, usually linked to daily-life activities, is challenging. Then, the investigators aimed to test the optimal self-management that could be achieved in a reasonable manner carried forward through the Prochaska and DiClemente behavior-changing strategy in a follow-up of 18 months, compared to usual care. Our primary outcome is the between-group difference in HbA1c (%) levels.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
盲法说明
Outcomes' assessors will be masked to assigned interventions in all measurements they would perform.
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Outpatients diagnosed with type 2 diabetes mellitus - T2DM (HbA1c % - ≥ 6.5%, or taking at least one oral hypoglycaemic agent, or medical diagnosis);
- •To be regularly assisted by the Sistema Único de Saúde and to have been saw at least one year before randomization;
- •Readiness for behavior-changing within the pre-action stages: pre-contemplation, contemplation and preparation;
- •T2DM patient of challenging handling (e.g., frequent hypoglycaemic seizures, cardiovascular disease (CVD), etc.);
排除标准
- •Pregnant women;
- •People living with HIV/AIDS;
- •T2DM patients taking erythropoietin, recent blood loss, recent blood transfusion and severe anaemia;
- •T2DM patients with CVD under non-optimized treatment; or those that made any CVD procedure; or CVD event (e.g., myocardial infarction) within three months before randomization;
- •T2DM patients with severe eye and retine disease;
- •Patients participating in another study simultaneously;
- •Patients living with others in the same place.
结局指标
主要结局
Glycemic control
时间窗: at 3-monthly intervals during 18 month
Glycemic control as measured by glycated haemoglobin (HbA1c) levels (%)
次要结局
- Number of hypoglycemiants, anti-hypertensives and hypolipidemic drugs(at 6-monthly intervals during 18 month)
- All-cause number of health care settings visits(at 6-monthly intervals during 18 month)
- Blood Pressure control(at 6-monthly intervals during 18 month)
- Body mass index(at 6-monthly intervals during 18 month)
- Abdominal circumference(at 6-monthly intervals during 18 month)
- High density lipoprotein levels - HDL-C(at 3-monthly intervals during 18 month)
- Diabetes Attitude Questionnaire (ATT-19)(at 6-monthly intervals during 18 month)
- Attributable number of health care settings visits to type 2 diabetes mellitus(at 6-monthly intervals during 18 month)
- Weight(at 6-monthly intervals during 18 month)
- Physical activity levels - Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ) - Short Form(at 6-monthly intervals during 18 month)
- Anxiety scores - Hamilton Anxiety Rating Scale (HAM-A)(at 6-monthly intervals during 18 month)
- Total cholesterol levels - TC(at 3-monthly intervals during 18 month)
- Height(at 6-monthly intervals during 18 month)
- Depression scores by Hamilton Depression Rating Scale - HDR-S(at 6-monthly intervals during 18 month)
- Creatinine levels(at 3-monthly intervals during 18 month)
- Low density lipoprotein levels - LDL-C(at 3-monthly intervals during 18 month)
- Total triglycerides levels - TG(at 3-monthly intervals during 18 month)
- MARKERS OF FOOD CONSUMPTION - Food and nutrition surveillance system - Brazil(at 6-monthly intervals during 18 month)
- Diabetes Mellitus knowledge (DKN-A)(at 6-monthly intervals during 18 month)
